1st Quarter - Report — BUCHANAN INGERSOLL & ROONEY PC for MYADERM (2020)

Firm

BUCHANAN INGERSOLL & ROONEY PC

Client

MYADERM

Income

$20,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

FDA Policy regarding CBD transdermal pain products

Lobbyist	Covered position, as disclosed
TIMOTHY COSTA	—
MICHAEL P STRAZZELLA	—
ELIZABETH WESTBROOK	—

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Health Issues HCR

FDA Policy regarding CBD transdermal pain products

Lobbyist	Covered position, as disclosed
TIMOTHY COSTA	—
MICHAEL P STRAZZELLA	—
ELIZABETH WESTBROOK	—

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Pharmacy PHA

FDA Policy regarding CBD transdermal pain products

Lobbyist	Covered position, as disclosed
TIMOTHY COSTA	—
MICHAEL P STRAZZELLA	—
ELIZABETH WESTBROOK	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.